Travelers' Suit Dropped From Neurontin MDL

Law360, New York (February 13, 2013, 4:26 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation on Tuesday removed from a New Jersey MDL a complaint by Travelers Indemnity Co. that alleges Pfizer Inc. conspired to bar competition for its epilepsy treatment Neurontin and promoted off-label uses for the drug.

The panel granted the insurers’ motion to vacate an earlier order from the panel transferring Travelers’ July suit, which was originally filed in Connecticut federal court, to the MDL. The JPML said it wouldn’t be convenient or efficient to include the complaint, even though the...
To view the full article, register now.